33 Amendments of Jean-François JALKH related to 2014/2207(INI)
Amendment 8 #
Motion for a resolution
Recital C
Recital C
C. whereas it is estimated that between 8 % and 12 % of patients admitted to hospitals in the EU suffer from adverse eventsmanifest shortcomings exist in hospitals in certain Member States as regards adverse events affecting patients admitted to them while receiving healthcare, and whereas nearly half of these events could be avoided;
Amendment 9 #
Motion for a resolution
Recital C a (new)
Recital C a (new)
Ca. whereas the prevalence of these defects varies between Member States and whereas therefore Member States should be free to take measures appropriate to each national situation;
Amendment 17 #
Motion for a resolution
Recital E
Recital E
E. whereas the current economic crisis isand the austerity measures imposed by the Commission are having a direct impact on patient safety, as many Member States have reduced budgets and staffing levels in their healthcare systems;
Amendment 22 #
Motion for a resolution
Recital F
Recital F
F. whereas electronic health (eHealth) and home-care medical treatments have a high potential for improving the quality and efficiency of medical treatments while contributing to a patient-centred approach and better healthcare performance, and whereas electronic health cannot take the place of genuine consultations;
Amendment 26 #
Motion for a resolution
Recital G
Recital G
G. whereas continuous training of doctors, and more generally of health professionals and hospital workers, is crucial to avoid adverse events, including adverse drug events (ADEs), which are estimated to cost the EU healthcare systems some EUR 2.7 billion per year in care expenses and account for 1.1 % of all hospitalisations in the EU;
Amendment 38 #
Motion for a resolution
Recital L
Recital L
L. whereas one of the main causes of antimicrobial resistance is the misinappropriate use of antimicrobials, including antibiotics, and in particular their excessive use;
Amendment 45 #
Motion for a resolution
Recital M
Recital M
M. whereas the use of antibiotics in animalspets or animals intended for consumption can affect antibiotic resistance in humans;
Amendment 58 #
Motion for a resolution
Recital N
Recital N
N. whereas antimicrobial resistance has increased worldwide for bacterial pathogens, leading to increasing prevalence of HAIs and treatment failures in human and animal infectious diseases at national, European and international levels; whereas the free movement of persons in the Schengen area contributes to the rapid spread of multidrug-resistant diseases; whereas this applies to the worrying phenomenon of multidrug-resistant tuberculosis, which particularly affects illegal immigrant populations, who in many cases are treated only at a late stage;
Amendment 104 #
Motion for a resolution
Paragraph 1
Paragraph 1
1. Welcomes the latest measures put in place by Member States to improve general patient safety and reduce the incidence of HAIs, and more particularly the progress made by Member States in developing patient safety strategies and reporting and learning systems, and recognises the national level as the only level capable of formulating and implementing public health policies;
Amendment 106 #
Motion for a resolution
Paragraph 2
Paragraph 2
2. Notes, however, that the second implementation report still shows uneven progress among Member States oObserves that, in certain Member States, shortcomings may exist in patient safety, and regrets the fact that some Member States have obviouslybeen compelled to slowed down implementation of the Council recommendations because of financial constraints resulting from the economic crisis;
Amendment 111 #
Motion for a resolution
Paragraph 3
Paragraph 3
3. Calls on Member States to make sure thatthe Commission to abandon austerity measures which could damage the healthcare system is not affected by austerity measures ands of the Member States and calls on Member States to ensure a sufficient number of healthcare professionals specialised in infection prevention and control, as well as hospital hygiene for a more patient-centred approach;
Amendment 114 #
Motion for a resolution
Paragraph 4
Paragraph 4
Amendment 120 #
Motion for a resolution
Paragraph 6 – point a
Paragraph 6 – point a
(a) continue their efforts to improve patient safety by taking, if they have not already done so, new measures in order to fully implement the Council’s recommendations;
Amendment 146 #
Motion for a resolution
Paragraph 7
Paragraph 7
7. Highlights the potential benefits of eHealth in reducing adverse events by tracking information flows and improving the understanding of medical processes, as well as through digital prescriptions and alerts on drug interaction; calls on the Commission and the Member States to further explore the possibilities offered by eHealth in the area of patient safety;
Amendment 156 #
Motion for a resolution
Paragraph 9
Paragraph 9
9. Calls on the European Medicines Agency (EMA) to develop guidelines on the off-label/unlicensed use of medicines based on medical need, as well as to compile a list of off-label medicines in use despite licenauthorised alternatives;
Amendment 167 #
Motion for a resolution
Paragraph 10
Paragraph 10
10. Invites the Member States to improve their reporting systems for adverse events and medical errors by developing measures that encourage accurate, blame-free and anonymous reporting by health professionals and patients; recalls the need to provide regular feedback to health professionals involved in reporting;
Amendment 173 #
Motion for a resolution
Paragraph 12
Paragraph 12
12. Invites the Member States to be more rigorous in verifying and enforcing the ban on non-medical external staff performing medical treatment; points out that this is happening with employees of companies that provide sophisticated medical machinery to hospitals; therefore, calls onsuggests that Member States to introduce a mandatory registration of the presence of product specialists during therapeutic treatments;
Amendment 178 #
Motion for a resolution
Paragraph 13
Paragraph 13
13. Calls on the Member States to provide for collective redress mechanisms in their national law, in accordance with the legal systems and traditions of each Member State, so as to allow the introduction of fair compensation systems for patients who have suffered an HAI or a medical error;
Amendment 180 #
Motion for a resolution
Paragraph 14
Paragraph 14
14. Invites the Commission to report onproduce a report reviewing national practices of collective redress in HAI-related cases and to launch a consultation aimed at debating the possibility of harmonising collective redress in HAI cases at European levelinform Parliament of the results;
Amendment 183 #
Motion for a resolution
Paragraph 15
Paragraph 15
15. Welcomes the Commission’s workeveryday work of the Member States’ medical teams on antimicrobial resistance and on the prevention and control of HAIs, as well as the coordination and surveillance efforts of the European Centre for Disease Prevention and Control (ECDC);
Amendment 200 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Welcomes and encourages further research for new antimicrobial drugs, in particular antibiotics with activity against prevalent multidrug-resistant Gram- negative bacteria such as K. pneumoniae and Acinetobacter, as well as for alternative methods aimed at fighting HAIs without using antibiotics, particularly involving the use of natural products;
Amendment 201 #
Motion for a resolution
Paragraph 19
Paragraph 19
19. Welcomes and encourages further research for new antimicrobial drugs, in particular antibiotics with activity against prevalent multidrug-resistant Gram- negative bacteria such as K. pneumoniae and Acinetobacter, as well as for alternative methods aimed at fighting HAIs without using antibiotics; recalls that the simplest hygiene measures are often the least costly and nonetheless effective and that they are a matter of remembering actions which are common sense on the part of patients themselves and people around them;
Amendment 210 #
Motion for a resolution
Paragraph 20
Paragraph 20
20. Considers it of paramount importance that the Commission should ensure the continuation of the EU Action Plan on Antimicrobial Resistance post-2017, with an emphasis on theMember States should encourage measures to prevention and control of healthcare-associated infections;
Amendment 221 #
Motion for a resolution
Paragraph 21
Paragraph 21
Amendment 231 #
Motion for a resolution
Paragraph 22 – introductory part
Paragraph 22 – introductory part
22. UrgesCalls on the Member States to implement or developstudy measures which have the following measurobjectives:
Amendment 235 #
Motion for a resolution
Paragraph 22 – point a
Paragraph 22 – point a
(a) regulatationalise the prescription of antibiotics for treatment or prophylaxis so that an appropriate use of medicines is ensured, specifying the therapeutic objective and selecting the appropriate drug therapy;
Amendment 243 #
Motion for a resolution
Paragraph 22 – point b
Paragraph 22 – point b
(b) improve regulateion of the sale of antibiotics so that patients can buy only the specific quantity of antibiotics as prescribed by their doctors;
Amendment 253 #
Motion for a resolution
Paragraph 22 – point e
Paragraph 22 – point e
(e) intensify infection control, in particular from a cross-border perspective, by properly screening patients transferred from a country/region/hospital known for its high prevalence of multidrug-resistant bacteria or even apply Article 2(2) of the Convention implementing the Schengen Agreement;
Amendment 256 #
Motion for a resolution
Paragraph 22 – point e a (new)
Paragraph 22 – point e a (new)
(ea) leave Member States free to institute the appropriate measures at their national borders concerning migrants from high- risk areas;
Amendment 273 #
Motion for a resolution
Paragraph 23 – introductory part
Paragraph 23 – introductory part
23. Calls on the Member States to introduce or developstudy measures which have the following measurobjectives:
Amendment 299 #
Motion for a resolution
Paragraph 24
Paragraph 24
24. Urges the Member States to regulate any conflicts of interest involving veterinarians who both sell and prescribeRecalls that decoupling the prescription and sale of antibiotics by veterinarians is not the solution to abusive prescribing practices and that veterinarians have already taken steps to reduce prescribing of antibiotics, with encouraging results as regards the resistance observed; calls on Member States to take measures to avoid promoting types of farming in which several thousand animals are concentrated in one place, which increase health risks and the consumption of antibiotics;
Amendment 303 #
Motion for a resolution
Paragraph 24 a (new)
Paragraph 24 a (new)
24a. Calls on Member States to improve the training of veterinarians, who are major prescribers of antibiotics, particularly by encouraging them to exploit diagnostic tools to identify the most appropriate antibiotic;
Amendment 319 #
Motion for a resolution
Paragraph 26
Paragraph 26
26. Calls on the Commission and the Member States to further engage in a dialogue with all stakeholders and developstudy a coordinated, comprehensive and sustainable EU strategy for patient safety in the Member States, as well as to put forwardformulate concrete solutions to be implemented at EU, national, regional, locwhich could be adapted to national and/or primary care levels;